Recherche
Résultats 1-10 de 14
-
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059
BLOOD, 05-2017, 129 (20), 2808-2810Article dans une revue scientifique -
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Journal of clinical oncology, 2017, 35, 2473Article dans une revue scientifique -
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials
Journal of clinical oncology, 2017, 35, 552Article dans une revue scientifique -
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients
Human pathology, 2017, 64, 128-136Article dans une revue scientifique -
Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma
The New England journal of medicine, 28-09-2017, 377, 1250-1260Article dans une revue scientifique -
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Journal of Oncology Practice, 02-2017, 35 (5), 536-543Article dans une revue scientifique -
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
Journal of clinical oncology, 2017, 35, 1905-+Article dans une revue scientifique -
Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment
Bulletin du cancer, 2017, 104, 221-231Article dans une revue scientifique -
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Blood, 2017, 129, 2616-2623Article dans une revue scientifique -
Allogeneic hematopoietic cell transplantation for Hodgkin''s disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bulletin du cancer, 2017, 104, S112-S120Article dans une revue scientifique